These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33351351)

  • 21. A novel compound heterozygous variant in CYP19A1 resulting in aromatase deficiency with normal ovarian tissue.
    Acar S; Erbaş İM; Paketçi A; Onay H; Çankaya T; Gürsoy S; Özhan B; Abacı A; Özer E; Olguner M; Böber E; Demir K
    Turk J Pediatr; 2020; 62(5):826-830. PubMed ID: 33108086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
    Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
    Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene.
    Hauri-Hohl A; Meyer-Böni M; Lang-Muritano M; Hauri-Hohl M; Schoenle EJ; Biason-Lauber A
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):39-43. PubMed ID: 21521281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect.
    Marino R; Perez Garrido N; Costanzo M; Guercio G; Juanes M; Rocco C; Ramirez P; Warman DM; Ciaccio M; Pena G; Feyling JG; Miras M; Rivarola MA; Belgorosky A; Saraco N
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E301-7. PubMed ID: 25415177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
    Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
    J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.
    Stratakis CA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4676-81. PubMed ID: 24311795
    [No Abstract]   [Full Text] [Related]  

  • 27. 46,XX aromatase deficiency: A single-center experience with the varied spectrum and recurrent variants, and a systematic review of hormonal parameters.
    Yami Channaiah C; Memon SS; Sarathi V; Lila AR; Barnabas R; Raghav D; Bhandare VV; Arya S; Thakkar H; Patil VA; Karlekar M; Kunwar A; Bandgar T
    Ann Endocrinol (Paris); 2024 Feb; 85(1):48-55. PubMed ID: 37348676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatase deficiency in a male patient - Case report and review of the literature.
    Miedlich SU; Karamooz N; Hammes SR
    Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase deficiency: a rare cause of maternal virilisation and ambiguous genitalia in neonates.
    Alsaleem M; Miller DE; Saadeh L; Majumdar I
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31208983
    [No Abstract]   [Full Text] [Related]  

  • 30. Child with '46, XX' disorder of sex development: clues to diagnose aromatase deficiency.
    Agrawal SS; Chakraborty PP; Sinha A; Maiti A
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31801784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription.
    Stratakis CA; Vottero A; Brodie A; Kirschner LS; DeAtkine D; Lu Q; Yue W; Mitsiades CS; Flor AW; Chrousos GP
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1348-57. PubMed ID: 9543166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood.
    Eklioglu BS; Atabek ME; Akyurek N; Piskin MM; Kılınc M
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):593-4. PubMed ID: 24825080
    [No Abstract]   [Full Text] [Related]  

  • 33. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
    Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Bulun SE
    N Engl J Med; 2003 May; 348(19):1855-65. PubMed ID: 12736278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local aromatase excess with recruitment of unusual promoters of
    Deberles E; Durand I; Mittre H; Reznik Y; Morera J
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):924-930. PubMed ID: 35667691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.
    Janner M; Flück CE; Mullis PE
    Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gynaecomastia--pathophysiology, diagnosis and treatment.
    Narula HS; Carlson HE
    Nat Rev Endocrinol; 2014 Nov; 10(11):684-98. PubMed ID: 25112235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aromatase deficiency: an unusual cause for primary amenorrhea with virilization.
    Sudeep K; Abraham J; Seshadri L; Seshadri MS
    J Assoc Physicians India; 2013 May; 61(5):340-3. PubMed ID: 24482950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.
    Riedl S; Springer A; Häusler G; Price G; Richter-Unruh A; Stener-Victorin E; Wudy SA
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3115-20. PubMed ID: 23824416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary gynaecomastia.
    LJUNGBERG T
    Acta Med Scand; 1960 Dec; 168():371-9. PubMed ID: 13762869
    [No Abstract]   [Full Text] [Related]  

  • 40. Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
    Fukami M; Shozu M; Soneda S; Kato F; Inagaki A; Takagi H; Hanaki K; Kanzaki S; Ohyama K; Sano T; Nishigaki T; Yokoya S; Binder G; Horikawa R; Ogata T
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E1035-43. PubMed ID: 21470988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.